These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10736983)

  • 21. [A comparative clinical evaluation of the antidepressive activity of fluoxetine and fluvoxamine].
    Lopukhov IG
    Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(4):53-7. PubMed ID: 9214192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Central analgesic effects of antidepressant drugs with various mechanisms of action: desipramine, fluvoxamine and moclobemide].
    Coquoz D; Porchet HC; Dayer P
    Schweiz Med Wochenschr; 1991 Dec; 121(49):1843-5. PubMed ID: 1754870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A double-blind controlled study of the efficacy and acceptability of tianeptine in comparison with fluvoxamine in the treatment of depressed alcoholic patients].
    Habrat B; Załoga B
    Psychiatr Pol; 2006; 40(3):579-97. PubMed ID: 17037821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Secondary dermatologic effects of serotonin reuptake inhibitor antidepressants: hypothesis of cross-reacting allergy. Apropos of 2 cases].
    Beauquier B; Fahs H
    Encephale; 1998; 24(1):62-4. PubMed ID: 9559306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluvoxamine versus fluoxetine in major depressive episode: a double-blind randomised comparison.
    Dalery J; Honig A
    Hum Psychopharmacol; 2003 Jul; 18(5):379-84. PubMed ID: 12858325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The antidepressant fluvoxamine increases natural killer cell counts in cancer patients.
    Ballin A; Gershon V; Tanay A; Brener J; Weizman A; Meytes D
    Isr J Med Sci; 1997 Nov; 33(11):720-3. PubMed ID: 9434807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evaluating quality of life of depressed patients in ambulatory care treatment].
    Dazord A; Noël F
    Encephale; 1996; 22(4):247-54. PubMed ID: 8940631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Risk of hemorrhage with the use of fluoxetine (Prozac) or fluvoxamine (Fevarin)].
    Ottervanger JP; van den Bemt PM; de Koning GH; Stricker BH
    Ned Tijdschr Geneeskd; 1993 Jan; 137(5):259-61. PubMed ID: 8433763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluoxetine and fluvoxamine combined with individual cognitive-behaviour therapy in binge eating disorder: a one-year follow-up study.
    Ricca V; Mannucci E; Mezzani B; Moretti S; Di Bernardo M; Bertelli M; Rotella CM; Faravelli C
    Psychother Psychosom; 2001; 70(6):298-306. PubMed ID: 11598429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emergence of depressive symptoms during treatment for panic disorder with specific 5-hydroxytryptophan reuptake inhibitors.
    Fux M; Taub M; Zohar J
    Acta Psychiatr Scand; 1993 Oct; 88(4):235-7. PubMed ID: 8256637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patterns of symptom improvement during antidepressant treatment of delusional depression.
    Serretti A; Lattuada E; Zanardi R; Franchini L; Smeraldi E
    Psychiatry Res; 2000 May; 94(2):185-90. PubMed ID: 10808044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of analgesic action of fluvoxamine compared with efficacy of imipramine and tramadol for treatment of sciatica--open trial].
    Kwasucki J; Stepień A; Maksymiuk G; Olbrych-Karpińska B
    Wiad Lek; 2002; 55(1-2):42-50. PubMed ID: 12043315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine.
    Uzunova V; Sheline Y; Davis JM; Rasmusson A; Uzunov DP; Costa E; Guidotti A
    Proc Natl Acad Sci U S A; 1998 Mar; 95(6):3239-44. PubMed ID: 9501247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacovigilance of new antidepressants: evaluation of neuro-psychobehavioral disorders].
    Blayac JP; Hillaire-Buys D; Peyrière H
    Therapie; 1997; 52(2):117-22. PubMed ID: 9231505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Fluvoxamine (fevarin) in psychogenic depression].
    Dubnitskaia EB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(12):48-50. PubMed ID: 11811127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pilot study: fluvoxamine treatment for depression and anxiety disorders in children and adolescents with cancer.
    Gothelf D; Rubinstein M; Shemesh E; Miller O; Farbstein I; Klein A; Weizman A; Apter A; Yaniv I
    J Am Acad Child Adolesc Psychiatry; 2005 Dec; 44(12):1258-62. PubMed ID: 16292117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Yohimbine augmentation of fluvoxamine in refractory depression: a single-blind study.
    Cappiello A; McDougle CJ; Malison RT; Heninger GR; Price LH
    Biol Psychiatry; 1995 Dec; 38(11):765-7. PubMed ID: 8580232
    [No Abstract]   [Full Text] [Related]  

  • 38. Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial.
    Lustman PJ; Freedland KE; Griffith LS; Clouse RE
    Diabetes Care; 2000 May; 23(5):618-23. PubMed ID: 10834419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carbamazepine coadministration with fluoxetine or fluvoxamine.
    Spina E; Avenoso A; Pollicino AM; Caputi AP; Fazio A; Pisani F
    Ther Drug Monit; 1993 Jun; 15(3):247-50. PubMed ID: 8333006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy, tolerability and side-effect profile of fluvoxamine for major depression: meta-analysis.
    Omori IM; Watanabe N; Nakagawa A; Akechi T; Cipriani A; Barbui C; McGuire H; Churchill R; Furukawa TA;
    J Psychopharmacol; 2009 Jul; 23(5):539-50. PubMed ID: 18562407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.